InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Louria Hayon Igal. Officer active across 1 company, notably Raphael Pharmaceutical Inc.. In total, 2 filings have been published. History available since 29 August 2023. The latest transaction was filed on 20 November 2025 (X). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations